-
expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies. ROLE
-
will identify, develop, and lead scientific strategies to support group goals and set direction for the group. The candidate is expected to work independently using their own ideas, knowledge, and
-
, animal/imaging technologists, administrative personnel, and clinical counterparts to develop MRI protocols including pulse sequences, post-processing protocols, and analysis protocols. The Pre-Clinical MRI
-
characterize and develop large and small molecules in close collaboration with partner lines as an integral member of the drug discovery teams. You will employ and develop cutting edge in vivo cancer models and
-
Persil and Schwarzkopf, our cutting-edge technologies and our disruptive solutions, you will have countless opportunities to explore new paths and develop your skills. Grow within our future-led businesses
-
preparation, use and maintenance of appropriate equipment, and preparation of relevant reagents. Train other analysts on established technologies and supervise junior staff. Qualifications Must-Have General
-
of the payload in antibody-based therapeutic activity and behavior. How You Will Achieve It Develop novel LC and MS methods for quantitative and qualitative analysis of small molecules of different therapeutic
-
required documentation for laboratory work. This includes information and data organization/review. After proficiency is demonstrated and experience is obtained, the incumbent may be asked to train, or
-
Role Summary The ADC Chemistry (AC) group is seeking a highly motivated, creative, and experienced medicinal chemist to develop novel payloads for antibody-drug conjugates (ADCs). You will apply
-
) at Pfizer combines research and technology units that have deep disease area expertise and cutting-edge science and platforms to discover and develop innovative therapeutic programs in small molecules and